Clinical significance of T-Wave alternans in hypertrophic cardiomyopathy

被引:25
作者
Kuroda, N
Ohnishi, Y
Yoshida, A
Kimura, A
Yokoyama, M
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Tokyo Med & Dent Univ, Med Res Inst, Div Adult Dis, Dept Mol Pathogenesis, Tokyo, Japan
关键词
disarray; hypertrophic cardiomyopathy; T-wave alternans; ventricular tachyarrhythmia;
D O I
10.1253/circj.66.457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical significance of T-wave alternans (TWA) in hypertrophic cardiomyopathy (HCM) is unclear, so SV1+RV5 and QT dispersion on 12-lead electrocardiograms (EGG), the parameters of the left ventricle on echocardiography and the family history of HCM and sudden death were investigated in 53 patients with HCM who experienced TWA. The maximal numbers of successive ventricular ectopic beats (max VE) and nonsustained ventricular tachycardia (NSVT) were measured by Holler monitoring. In 13 patients, genetic abnormalities were examined. In 22 patients, the hypertrophy of myocytes, disarray and fibrosis were histopathologically examined using a scoring method. TWA was positive in 27 patients (TWA+ group), negative in 14 (TWA- group) and indeterminate in 12. The ECG and echocardiographic parameters, family history and genetic abnormalities did not significantly differ between the TWA+ and TWA- groups. Max VE, the percentage of patients with NSVT and disarray score in the TWA+ group were significantly higher than those in the TWA- group (3.6+/-3.6 vs 1.3+/-0.7, 37% vs 0%, 1.9+/-1.1 vs 0.7+/-0.5; p<0.05). TWA in HCM correlates with histopathological changes, especially disarray and ventricular tachyarrhythmia, and measuring it may be a noninvasive means of detecting high-risk patients with HCM.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 38 条
[1]   Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy [J].
Adachi, K ;
Ohnishi, Y ;
Shima, T ;
Yamashiro, K ;
Takei, A ;
Tamura, N ;
Yokoyama, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (02) :374-380
[2]   Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-Wave alternans [J].
Adachi, K ;
Ohnishi, Y ;
Yokoyama, M .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (02) :76-80
[3]   COMPARISON OF QT DISPERSION IN HYPERTROPHIC CARDIOMYOPATHY BETWEEN PATIENTS WITH AND WITHOUT VENTRICULAR ARRHYTHMIAS AND SUDDEN-DEATH [J].
BUJA, G ;
MIORELLI, M ;
TURRINI, P ;
MELACINI, P ;
NAVA, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (12) :973-976
[4]   NATURAL-HISTORY OF HYPERTROPHIC CARDIOMYOPATHY - A POPULATION-BASED STUDY, 1976 THROUGH 1990 [J].
CANNAN, CR ;
REEDER, GS ;
BAILEY, KR ;
MELTON, LJ ;
GERSH, BJ .
CIRCULATION, 1995, 92 (09) :2488-2495
[5]   IDENTIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AT HIGH-RISK FOR SUDDEN-DEATH [J].
CHANG, AC ;
MCAREAVEY, D ;
FANANAPAZIR, L .
CURRENT OPINION IN CARDIOLOGY, 1995, 10 (01) :9-15
[6]  
CRIPPS TR, 1990, J AM COLL CARDIOL, V12, P759
[7]   DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J].
EPSTEIN, ND ;
COHN, GM ;
CYRAN, F ;
FANANAPAZIR, L .
CIRCULATION, 1992, 86 (02) :345-352
[8]   PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS [J].
FANANAPAZIR, L ;
CHANG, AC ;
EPSTEIN, SE ;
MCAREAVEY, D .
CIRCULATION, 1992, 86 (03) :730-740
[9]   Time-domain signal-averaged electrocardiogram in nonischemic ventricular tachycardia [J].
Fauchier, JP ;
Fauchier, L ;
Babuty, D ;
Cosnay, P .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (02) :231-244
[10]  
GANG Y, 1998, AM J CARDIOL, V82, P1514